Teva unveils generic version of Lipitor in UK
The generic version of Pfizer’s Lipitor is indicated for the treatment of hypercholesterolaemia and to prevent cardiovascular disease. The company is launching the product in Teva 360 livery,
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.